The top healthcare technology companies worldwide are checking for robotics application in intricate knee surgery, anticipating faster operations and enhanced outcomes post surgery. As often the result of these types of surgeries is patients’ disappointment.
Artificial replacement joints’ demand is increasing rapidly, as hips and knees wear out, however for the past 10 yearsplus, these rival healthcare giants have failed to bring a technology advancement to achieve major market share.
However, currently, Stryker Corporation from the United States and Smith & Nephew Healthcare from Great Britain believe that it is about to change, as robotics is an emerging edge of the healthcare sector. The robots are supposed to give less pain and trouble and quicker recovery to patients, though they yet need to testify with determinate medical studies, which will take them approximately couple of years for results to come out.
A specialist surgeon at University College London Hospitals, Dr. Fares Haddad is one of the first in the United Kingdom to employ robots in clinical surgery and has been impressed with their performance. Although, he believes that healthcare supplier companies required significant statistics to confirm that robots deserve an investment. As the investment could possibly cost approximately USD 1 million per robot.
Dr. Fares Haddad said that the major motive for employing a robotic system is to get better precision as well as to be able to operate the targeted tissue and bone that differsin each patient with extreme accuracy, he further added that It is especially helpful in knees as they are more complicated than hips and there are a numerous patients who are not satisfied with the knee replacement. According to industry reviews, the gratification rates are just 65% for knee surgeries, against 95% for hips surgeries.
The competitor types of robots contrast in sophistication and cost, supporting surgeons with accurate picture guidance for cutting bone and the incorporation of artificial joints.
Both companies, Stryker and Smith & Nephew trust that their robots will assist them to capture a larger share of an orthopedic healthcare industry that has been divided among four key players for more than 10 years.